Literature DB >> 1569352

Drug resistance of Helicobacter pylori: memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter, and Related Organisms.

T U Westblom, P Unge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1569352     DOI： 10.1093/infdis/165.5.974

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  In vitro activities of new quinolones against Helicobacter pylori.

Authors:  M Carbone; M T Fera; V Cecchetti; O Tabarrini; E Losi; V Cusumano; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 2.  Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.

Authors:  A Burette; Y Glupczynski
Journal:  Infection       Date:  1995       Impact factor: 3.553

3.  vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori.

Authors:  S R Han; H J Schreiber; S Bhakdi; M Loos; M J Maeurer
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

4.  In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).

Authors:  T U Westblom; B R Midkiff; S J Czinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.